Clinical trials

Global top pharmaceutical companies based on R&D spending 2024

Top 50 global pharmaceutical and biotech companies by R&D intensity in 2016/2017

Top pharmaceutical companies in R&D spending growth 2016-2017

Roche: participation of patients in clinical trials 2009-2017

Leading global contract research organizations based on revenue 2017

Investments made by clinical research organizations by phase 2009-2014

Comparison between the complexity of clinical trials 2001-2015

Increase in clinical trials' complexity 2001-2015

Number of registered clinical studies by location worldwide 2018

Percent of registered clinical studies worldwide by location 2018

Share of recruiting clinical studies worldwide by location 2018

Total number of registered clinical studies worldwide since 2000

Total number of registered clinical studies with posted results worldwide 2009-2017

U.S. drug development Phase success rates 2006-2015

U.S. drug development Phase II success rates 2006-2015, by disease area

U.S. drug development Phase III success rates from 2006 to 2015, by disease area

U.S. development Phase success rates for oncology and non oncology drugs 2006-2015

U.S. drug development Phase success rates, by drug classification 2006-2015

U.S. development phase success rates for drugs with and without biomarkers 2006-2015

Pharmaceuticals: cost of drug development in the U.S. since 1975

Leading orphan drugs based on R&D phase III cost 2015

Average per-study costs by trial phase

Total per-study costs by clinical trial phase and therapeutic area

Clinical trial costs by select component and phase

Average per-patient clinical trial costs in U.S. 2013, by selected condition

Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase

Number of new drugs launched in the U.S. 2003-2015

Pharmaceutical industry - number of new substances 1992-2017

First world new molecular entities launched 2004-2015

FDA first premarket approvals for medtech products granted 2005-2017

NDA/BLA filing to FDA approval times for new drugs in select disease areas 2006-2015

Number of unsuccessful Alzheimer’s drugs in development in the U.S. 1998-2014

Unsuccessful developing melanoma drugs in the U.S. 1998-2014

Unsuccessful developing lung cancer drugs in the U.S. 1998-2014